Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2011, Article ID 727634, 9 pages
http://dx.doi.org/10.4061/2011/727634
Research Article

Modelling Cost-Effectiveness of Biologic Treatments Based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain

1R&D, Data Mining International, 1215 Geneva, Switzerland
2LIRAES, Paris Descartes University, 75270 Paris cedex 06, France
3Rheumatology, Hospital Universitario Virgen Macarena, 41007 Sevilla, Spain
4Rheumatology, Hospital de Basurto, 48013 Bilbao, Spain
5Pharmacoeconomics Department, Bristol-Myers Squibb, Iberia, 28040 Madrid, Spain
6Health Economics and Outcomes Strategy, Bristol-Myers Squibb Europe, 1420 Braine-l'Alleud, Belgium

Received 14 February 2011; Accepted 2 May 2011

Academic Editor: B. L. Slomiany

Copyright © 2011 Ariel Beresniak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ariel Beresniak, Rafael Ariza-Ariza, Jose Francisco Garcia-Llorente, Antonio Ramirez-Arellano, and Danielle Dupont, “Modelling Cost-Effectiveness of Biologic Treatments Based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain,” International Journal of Inflammation, vol. 2011, Article ID 727634, 9 pages, 2011. https://doi.org/10.4061/2011/727634.